Clinical Trials Browser

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Anatomic Stage I Breast Cancer AJCC v8

Advanced Solid Tumour

Solid Tumors

Carcinoma, Oropharyngeal Neoplasms

Breast Neoplasms

Metastatic Castration-Resistant Prostate Cancer

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7

Salivary Gland Neoplasms

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

HER2-positive Early-stage Breast Cancer

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Metastatic Non-Squamous Non-Small Cell Lung Cancer

Anatomic Stage I Breast Cancer AJCC v8

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Carcinoma, Squamous Cell, Laryngeal Diseases

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Breast Neoplasms

Carcinoma, Squamous Cell

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Urinary Bladder Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Vaccinia

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Breast Neoplasms

Adenocarcinoma

Breast Neoplasms

Breast Neoplasms

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Pathologic Complete Response, Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

MK-3475-01I

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

NeoTHERa

InavoPC

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

EmpowHER 208

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

(NeoScorch HN)

EUREKA

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

IMMUNOLIFE2

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

CAMPFIRE

ctDNA in HER2+ EBC Neoadjuvant Treatment

Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

VELOCITY-Lung

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Intravesical Gem/Doce in Patients With NMIBC

TARMAC

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

VIRO-25

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

ARIADNE

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

BRE-10

The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

Toripalimab With Chemotherapy for Sinus Cancer

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

HGNMIBC